Breaking News Instant updates and real-time market news.

RTN

Raytheon

$192.36

2.13 (1.12%)

, LMT

Lockheed Martin

$328.16

-1.52 (-0.46%)

16:45
01/08/18
01/08
16:45
01/08/18
16:45

Trump finalizing plan to raise int'l money for U.S. weapons makers, Reuters says

The Trump administration is close to finalizing its new "Buy American" plan that calls for U.S. military attaches and diplomats to help raise billions of dollars more in business overseas for the U.S. arms industry, Reuters reports, citing officials. The president is expected to announce a "whole of government" approach that will also ease export rules on U.S. military exports and give more weight to the economic benefits for U.S.-based manufacturers in a decision-making process has has long focused greatly on human rights considerations, the report says, citing people familiar with the plan. The initiative is anticipated to be launched as soon as February, the report says. Publicly traded companies in the space include BAE Systems (BAESY), Boeing (BA), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC), Raytheon (RTN) and United Technologies (UTX). Reference Link

RTN

Raytheon

$192.36

2.13 (1.12%)

LMT

Lockheed Martin

$328.16

-1.52 (-0.46%)

GD

General Dynamics

UTX

United Technologies

$132.82

1.25 (0.95%)

NOC

Northrop Grumman

$308.26

0.04 (0.01%)

BAESY

BAE Systems

$31.55

0.055 (0.17%)

BA

Boeing

$310.15

1.31 (0.42%)

  • 10

    Jan

  • 24

    Jan

  • 25

    Jan

  • 31

    Jan

  • 21

    Feb

  • 07

    Mar

RTN Raytheon
$192.36

2.13 (1.12%)

12/12/17
12/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Juno Therapeutics (JUNO) downgraded to Market Perform from Outperform at Wells Fargo, with analyst Jim Birchenough saying that while data for JCAR017 continue to support a potential best-in-class profile in aggressive lymphoma, the current valuation already reflects dominant market positioning over Gilead's (GILD) Yescarta. 2. General Dynamics (GD) downgraded to Underweight from Neutral at JPMorgan, with analyst Seth Seifman saying Gulfstream questions are unlikely to be resolved in the near term. Demand for G500/600 is ok for now, but uncertainty about ultimate production levels and the pace of the learning curve mean the transition will remain a near term overhang, the analyst said. Seifman also downgraded Raytheon (RTN) to Neutral from Underweight. 3. Adobe (ADBE), Barracuda (CUDA), GoDaddy (GDDY), Fortinet (FTNT) and Check Point (CHKP) downgraded to Neutral from Overweight and CoStar Group (CSGP), Imperva (IMPV) and Monotype Imaging (TYPE) downgraded to Underweight from Overweight at JPMorgan by analyst Sterling Auty in conjunction with his 2018 annual outlook for Software Technology. The analyst does not expect the "exceptional performance" in Software during 2017 to repeat in 2018. 4. Spark Therapeutics (ONCE) downgraded to Neutral from Buy at UBS, with analyst Carter Gould seeing a "challenging setup" for the shares after the Phase 1/2 SPK-8011 data in hemophilia A fell short of expectations. The analyst removed SPK-8011, or $29 per share, and early-stage pipeline value, or $12 per share, from his model. He finds it difficult to be more constructive on Spark shares in the near-term. 5. Electronic Arts (EA) downgraded to Buy from Conviction Buy at Goldman Sachs by analyst Christopher Merwin to reflect fewer near-term catalysts around in-game monetization of non-sports titles. To see The Fly's full Street Research coverage, click here.
12/12/17
JPMS
12/12/17
DOWNGRADE
Target $210
JPMS
Neutral
Raytheon downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Seth Seifman downgraded Raytheon ((RTN) to Neutral while raising his price target for the shares to $210 from $190. The analyst cites valuation for the downgrade following the stock's strong performance. He believes Raytheon has well positioned defense franchises but feels Northrop Grumman (NOC) offers more upside.
12/05/17
BERN
12/05/17
NO CHANGE
BERN
Defense earnings, free cash flow should benefit from tax reform, says Bernstein
Bernstein analyst Douglas Harned believes Defense earnings and free cash flow should benefit substantially in the near-term from Senate and House bills that lower the corporate tax rate from 35% to 20%, as large U.S. defense companies currently pay effective tax rates of 25%-30%. The analyst expects those effective rates to move to a 16%-20% range. Harned prefers Raytheon (RTN) among major U.S. defense contractors, based on international sales, but believes Huntington Ingalls (HII) should benefit most from tax reform and Lockheed Martin (LMT) least.
11/28/17
WELS
11/28/17
NO CHANGE
Target $202
WELS
Outperform
Raytheon price target raised to $202 from $195 at Wells Fargo
Wells Fargo analyst Sam Pearlstein raised his price target for Raytheon to $202 from $195, while reiterating an Outperform rating on the shares. Although the adoption of ASU 2017-07 in 2018 will have no impact on reported EPS and cash flow, it will shift certain pension-related items from operating to non-operating, and therefore, reported EBIT will be affected. The analyst expects the ''optics'' of the change to benefit Raytheon's reported operating margin and EV/EBITDA multiples the most in his coverage universe.
LMT Lockheed Martin
$328.16

-1.52 (-0.46%)

10/09/17
RBCM
10/09/17
NO CHANGE
Target $209
RBCM
Outperform
Defense and Aerospace sector poised for strong Q3, says RBC Capital
RBC Capital analyst Matthew McConnell previewed the Q3 earnings season for the defense and commercial aviation industries, raising price targets across the sectors. In defense, McConnell likes the companies with focus on international markets, where demand has not yet been reflected in orders or backlog. Among his favorites, McConnell raises the price target on Raytheon (RTN) to $209 from $193, General Dynamics (GD) to $241 from $220, Northrop Grumman (NOC) to $324 from $294, Lockheed Martin (LMT) to $327 from $289, and Triumph (TGI) to $38 from $33. He also states that there may be room for some consolidation in defense given that budget up-cycle is only 2 years old, profiling Astronics (ATRO), Barnes (B), Esterline (ESL), Heico (HEI), and Textron (TXT) as some of the potential targets. In commercial aviation, McConnell sees Boeing (BA) upside driven by continued strong air traffic growth, mature sales campaigns, and expectations for a strong wide-body replacement cycle starting in the early 2020s, raising his price target on Boeing to $269 from $235.
10/25/17
FBCO
10/25/17
NO CHANGE
Target $308
FBCO
Neutral
Lockheed Martin price target raised to $308 from $300 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for Lockheed Martin to $308 from $300 following Q3 results. The analyst reiterates a Neutral rating on the shares.
10/27/17
BOFA
10/27/17
NO CHANGE
BOFA
Lockheed Martin price target raised to $360 from $335 at BofA/Merrill
BofA/Merrill analyst Ronald Epstein raised his price target on Lockheed Martin to $360 from $335 and reiterated a Buy rating on shares, saying in his view, the market may be missing Lockheed's strong free cash flow generation, record backlog, and shareholder friendly capital deployment strategy.
GD General Dynamics

12/12/17
JPMS
12/12/17
DOWNGRADE
Target $215
JPMS
Underweight
General Dynamics downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst Seth Seifman downgraded General Dynamics to Underweight and lowered his price target for the shares to $215 from $225. Gulfstream questions are unlikely to be resolved in the near term, Seifman tells investors in a research note. Demand for G500/600 is ok for now, but uncertainty about ultimate production levels and the pace of the learning curve mean the transition will remain a near term overhang, the analyst says.
10/26/17
FBCO
10/26/17
NO CHANGE
Target $238
FBCO
Outperform
General Dynamics price target raised to $238 from $216 at Credit Suisse
Credit Suisse analyst Robert Spingarn raised his price target for General Dynamics to $238 from $216 following quarterly results. The analyst reiterates an Outperform rating on the shares.
UTX United Technologies
$132.82

1.25 (0.95%)

01/08/18
01/08/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. United Technologies (UTX) upgraded to Buy from Neutral at Goldman Sachs with analyst Noah Poponak saying he believes United Technologies is within the year of maximum new engine loss on Geared Turbofan engines, or GTFs, and thinks the market will begin to look beyond that peak loss and give increased consideration to substantial longer-term cash flows. 2. Caterpillar (CAT) upgraded to Overweight from Neutral at JPMorgan with analyst Ann Duignan saying she believes the stock still has "significant upside" despite the outperformance in 2017. 3. Flir Systems (FLIR) upgraded to Buy from Hold at SunTrust with analyst Michael Ciarmoli citing the company's realigned segment structure under the new management team with a sharper focus on the larger government and industrial end-markets, forecasting outperformance driven by RAID order flow and new Department of Defense procurement initiatives. 4. Applied Materials (AMAT) upgraded to Strong Buy from Buy at Needham with analyst Y. Edwin Mok saying he is positive on the company's "balanced WFE exposure across segments" amid the likelihood of moderating NAND growth. 5. Western Union (WU) upgraded to Neutral from Negative at Susquehanna with analyst James Friedman saying he believes the company may be working with Ripple Labs to potentially implement blockchain applications in remittance and sees that as a possible accelerator with business-to-business. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/08/18
01/08/18
UPGRADE

Buy
United Technologies upgraded to Buy at Goldman Sachs
As previously reported, Goldman upgraded United Technologies to Buy from Neutral and raised its price target to $173 from $124. Analyst Noah Poponak believes United Technologies is within the year of maximum new engine loss on Geared Turbofan engines, or GTFs, and thinks the market will begin to look beyond that peak loss and give increased consideration to substantial longer-term cash flows. Poponak said shares trade near all time low valuation and notes, outside of the GTF, aerospace aftermarket and Defense end-market growth is accelerating, while Otis and CCss are stable, and tax reform and the pending Collins deal could both be accretive.
01/07/18
GSCO
01/07/18
UPGRADE
GSCO
Buy
United Technologies upgraded to Buy from Neutral at Goldman Sachs
01/05/18
BARD
01/05/18
UPGRADE
Target $156
BARD
Outperform
United Technologies upgraded to Outperform from Neutral at Baird
Baird analyst Peter Arment upgraded United Technologies (UTX) to Outperform from Neutral utilizing pro forma earnings of the pending Rockwell Collins (COL) deal and reflecting higher accretion from tax reform. Arment raised his price target to $156 from $121 on United Technologies shares.
NOC Northrop Grumman
$308.26

0.04 (0.01%)

11/28/17
BOFA
11/28/17
NO CHANGE
BOFA
Northrop Grumman added to US 1 List at BofA/Merrill
12/12/17
12/12/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Verizon (VZ) upgraded to Buy from Neutral at Nomura Instinet by analyst Jeffrey Kvaal, who said that better visibility into subscriber growth, rising average revenue per user and cost control will drive earnings growth in 2018. Further, he believes tax reform should also boost the company's earnings. The analyst thinks signs of easing competition may also spur multiple expansion. 2. Northrop Grumman (NOC) upgraded to Overweight from Neutral at JPMorgan by analyst Seth Seifman, who said that more profitable F-35 growth will accelerate in 2018 while management's initial take on the Orbital ATK (OA) deal, including synergies, will prove conservative. He called Northrop his top defense prime pick. 3. Activision Blizzard (ATVI) upgraded to Buy from Neutral at Goldman Sachs by analyst Christopher Merwin, who recommends owning this discounted "high-quality" asset ahead of accelerating earnings growth over the next 2-3 years. Merwin raised Activision's 2019 and 2020 estimates to reflect a robust pipeline of games including Diablo, Overwatch 2, and a Blizzard mobile title, which he does not believe Street estimates fully reflect. 4. Abbott (ABT) upgraded to Outperform from Market Perform at BMO Capital by analyst Joanne Wuensch, who said she is placing the stock on her "Top Picks" list, noting that 2018 will be the "year of execution" with several product launches ahead and acquisitions of Alere and St. June in the past. 5. HCA Healthcare (HCA), Tenet (THC) and Universal Health (UHS) upgraded to Buy from Neutral at Citi by analyst Ralph Giacobbe, who cited a more constructive view on the hospital space. The analyst sees a better volume backdrop in 2018 and low expectations for the sector. He believes hospital stocks offer an attractive upside scenario. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/12/17
JPMS
12/12/17
UPGRADE
JPMS
Overweight
Northrop Grumman upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Seth Seifman upgraded Northrop Grumman (NOC) to Overweight and raised his price target for the shares to $355 from $317. More profitable F-35 growth will accelerate in 2018 while management's initial take on the Orbital ATK (OA) deal, including synergies, will prove conservative, Seifman tells investors in a research note. He calls Northrop his top defense prime pick.
BAESY BAE Systems
$31.55

0.055 (0.17%)

06/23/17
JPMS
06/23/17
DOWNGRADE
JPMS
Neutral
BAE Systems downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst David Perry downgraded BAE Systems to Neutral from Overweight and removed the stock from the firm's Analyst Focus List citing valuation after the stock's 40% rally since the beginning of last year.
09/06/17
STFL
09/06/17
NO CHANGE
STFL
Stifel says United Tech deal strategic, not a sign of M&A 'floodgates opening'
Stifel analyst Joseph DeNardi said one of the only risks he sees to defense stocks' multiples would be a shift in cash deployment strategy from a focus on dividends and buybacks to M&A. However, he views United Technologies' (UTX) planned acquisition of Rockwell Collins (COL) as strategic and largely focused on its desire to regain leverage against Boeing (BA) and Airbus (EADSY) and not indicative of the M&A "floodgates opening" in the defense sector. Other publicly traded companies in the defense space include BAE Systems (BAESY), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
10/03/17
BREN
10/03/17
DOWNGRADE
BREN
Hold
BAE Systems downgraded to Hold from Buy at Berenberg
Berenberg analyst Charlotte Keyworth downgraded BAE Systems to Hold with a reduced price target of 600p. The analyst sees only modest earnings growth for BAE over two years.
04/18/17
RBCM
04/18/17
NO CHANGE
RBCM
Defense stocks should be bought on any weakness, says RBC Capital
RBC Capital analyst Matthew McConnell,recommends buying defense stocks on any weakness caused by near-term funding uncertainties. The analyst says that the impact of a government shutdown on the sector would be "minor and short-lived," while geopolitical tensions have increased. Publicly traded companies in the space include BAE Systems (BAESY), Boeing (BA), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC), Raytheon (RTN) and United Technologies (UTX).
BA Boeing
$310.15

1.31 (0.42%)

12/27/17
RHCO
12/27/17
NO CHANGE
Target $78
RHCO
Buy
KLX Inc. price target raised to $78 from $65 at SunTrust
SunTrust analyst Michael Ciarmoli raised his price target on KLX Inc. (KLXI) to $78 from $65 after the company reported that it has initiated a formal process to explore strategic alternatives, stating that he believes a divestiture of the energy segment could be followed by a sale of the aerospace solutions group to a larger tier one aerospace supplier. Adding KLX to Boeing's (BA) already established Aviall distribution arm could make strategic sense, added Ciarmoli, who keeps a Buy rating on KLX shares.
12/21/17
WELS
12/21/17
NO CHANGE
WELS
A Boeing acquisition of Embraer would be negative for Textron, says Wells Fargo
12/12/17
BOFA
12/12/17
NO CHANGE
Target $320
BOFA
Buy
Boeing price target raised to $320 from $290 at BofA/Merrill
BofA/Merrill analyst Ronald Epstein said Boeing's 20% quarterly dividend increase was above his expectations of a 10% increase and the new $18B repurchase plan was in line with his forecast. Epstein believes Boeing's ability to deploy capital in the form of buybacks and dividends and extract cash from the business outweigh long-term cyclical headwinds. The analyst raised his price target to $320 from $290 and reiterates a Buy rating on Boeing shares.
12/22/17
JEFF
12/22/17
NO CHANGE
Target $312
JEFF
Buy
Jefferies sees possible Embraer deal modestly accretive to Boeing
Jefferies analyst Sheila Kahyaoglu estimates an acquisition of Embraer (ERJ), done at a 40% premium, would be 2%, or 20c, accretive to Boeing's (BA) core earnings per share in 2020. While the transaction would be strategically beneficial for Boeing's commercial aircraft and services portfolio, it is not clear what restrictions the Brazilian government would place on any combination, Kahyaoglu tells investors in a research note. She has a Buy rating on Boeing with a $312 price target.

TODAY'S FREE FLY STORIES

03:05
01/22/18
01/22
03:05
01/22/18
03:05
General news
FX Update: The dollar dipped at the open of Asia-Pacific dealings »

FX Update: The dollar…

02:55
01/22/18
01/22
02:55
01/22/18
02:55
Conference/Events
Morgan Stanley transportation analysts hold an analyst/industry conference call »

ASEAN Transportation VP…

FCX

Freeport McMoRan

$19.96

0.56 (2.89%)

21:10
01/21/18
01/21
21:10
01/21/18
21:10
Downgrade
Freeport McMoRan rating change at CIBC »

Freeport McMoRan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

DCM

NTT DoCoMo

$24.74

0.08 (0.32%)

21:09
01/21/18
01/21
21:09
01/21/18
21:09
Downgrade
NTT DoCoMo rating change at HSBC »

NTT DoCoMo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$53.01

0.65 (1.24%)

, PETS

PetMed Express

$53.24

2.67 (5.28%)

20:25
01/21/18
01/21
20:25
01/21/18
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

HAL

Halliburton

$53.01

0.65 (1.24%)

PETS

PetMed Express

$53.24

2.67 (5.28%)

OPB

Opus Bank

$28.70

0.05 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

20:00
01/21/18
01/21
20:00
01/21/18
20:00
Hot Stocks
On The Fly: Top five weekend stock stories »

Catch up on the…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

SNE

Sony

$49.89

0.72 (1.46%)

BA

Boeing

$337.73

-2.43 (-0.71%)

WMT

Walmart

$104.59

0.29 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 30

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 07

    Feb

  • 20

    Feb

  • 21

    Feb

  • 28

    Feb

  • 18

    Mar

XRX

Xerox

$31.80

0.43 (1.37%)

19:18
01/21/18
01/21
19:18
01/21/18
19:18
Periodicals
Icahn, Deason pushing for Xerox to explored sale, WSJ reports »

Carl Icahn and Darwin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

18:22
01/21/18
01/21
18:22
01/21/18
18:22
Periodicals
Facebook to open three new digital training hubs in Europe, Reuters says »

Facebook said it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 28

    Feb

TWX

Time Warner

$93.36

0.39 (0.42%)

, CMCSA

Comcast

$42.50

0.65 (1.55%)

17:56
01/21/18
01/21
17:56
01/21/18
17:56
Hot Stocks
Box Office Battle: 'Jumanji' wins weekend with $20M »

Once again, Sony's…

TWX

Time Warner

$93.36

0.39 (0.42%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

SNE

Sony

$49.89

0.72 (1.46%)

FOX

21st Century Fox

$36.26

0.53 (1.48%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

LGF.A

Lionsgate

$35.42

0.92 (2.67%)

DIS

Disney

$110.59

0.17 (0.15%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 24

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

CTIC

CTI BioPharma

16:11
01/21/18
01/21
16:11
01/21/18
16:11
Conference/Events
CTI BioPharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ZSAN

Zosano Pharma

$0.45

-0.0387 (-7.92%)

16:00
01/21/18
01/21
16:00
01/21/18
16:00
Conference/Events
Zosano Pharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SANM

Sanmina

$35.45

0.5 (1.43%)

15:39
01/21/18
01/21
15:39
01/21/18
15:39
Conference/Events
Sanmina to hold a conference call »

Management holds an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

12:05
01/21/18
01/21
12:05
01/21/18
12:05
Periodicals
Amazon automated grocery store opens Monday, Reuters says »

Amazon will open its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

  • 18

    Mar

TWTR

Twitter

$23.66

-0.38 (-1.58%)

09:07
01/21/18
01/21
09:07
01/21/18
09:07
Periodicals
Twitter COO in discussions to become SoFi CEO, WSJ reports »

Twitter's COO,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

CLF

Cleveland-Cliffs

$8.49

0.08 (0.95%)

09:02
01/21/18
01/21
09:02
01/21/18
09:02
Hot Stocks
Cleveland-Cliffs addresses ''inaccurate media reports' on Nashwauk property »

Cleveland-Cliffs said it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.